Story

On air. The free wire runs 15 minutes behind live. See pricing

World, crypto, finance and tech news, scored for impact.

MarketsSEC EDGAR SCHEDULE 13GFiled 2 days ago

Orthofix Medical Inc.: ARMISTICE CAPITAL, LLC discloses a stake of more than 5% (Schedule 13G)

Open the sourceReported by SEC EDGAR SCHEDULE 13G, sec.gov, 16 November 2026, by SEC EDGAR SCHEDULE 13G

Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.

Armistice Capital LLC disclosed a stake exceeding 5% in Orthofix Medical Inc. via a Schedule 13G filing with the SEC (accession 0001172661-26-005278). The exact share count and percentage were not specified in the filing headline. The disclosure signals active institutional ownership in the medical device maker and could prompt investor scrutiny of Armistice's intentions. Watch for further 13G/13D amendments or proxy activity that clarify whether the position is passive or activist.

Muhabbit's AI wrote this summary in its own words from SEC EDGAR SCHEDULE 13G's report. It can get details wrong, so check the source.

Named in this story

Armistice Capital, LLC, Orthofix Medical Inc.